Viewing StudyNCT00300573



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00300573
Status: TERMINATED
Last Update Posted: 2018-08-23
First Post: 2006-03-07

Brief Title: Randomized Double-Blind Study Comparing Dexelvucitabine DFC to Lamivudine 3TC in Subjects With Resistance to NRTIs PIs and NNRTIs
Sponsor: Incyte Corporation
Organization: Incyte Corporation

Conditions & Keywords Data

Conditions:
Name
Human Immunodeficiency Virus
HIV Infections
Keywords:
Name View
HIV-1 View
dexelvucitabine View
DFC View
Treatment Experienced View